Amgen Narrows FY2026 GAAP EPS Guidance from $15.62-$17.10 to $15.80-$17.08 vs $15.44 Est
Amgen (NASDAQ: AMGN ) narrows FY2026 GAAP EPS guidance from $15.62-$17.10 to $15.80-$17.08 vs $15.44 analyst estimate..
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.